NuVasive, Inc.
NUVAFinancial Statements
Income Statement (Annual)
Amounts in millions
2022
12/31/2022
Revenue
1,202
Cost of Revenue
337
Gross Profit
865
Gross Margin
72.0%
Operating Income
65
Operating Margin
5.4%
Net Income
40
Net Margin
3.4%
EPS (Basic)
$0.78
EPS (Diluted)
$0.76
EBITDA
149
EBITDA Margin
12.4%
2021
12/31/2021
Revenue
1,139
Cost of Revenue
322
Gross Profit
817
Gross Margin
71.7%
Operating Income
31
Operating Margin
2.8%
Net Income
-64
Net Margin
-5.6%
EPS (Basic)
$-1.24
EPS (Diluted)
$-1.24
EBITDA
181
EBITDA Margin
15.9%
2020
12/31/2020
Revenue
1,051
Cost of Revenue
322
Gross Profit
729
Gross Margin
69.4%
Operating Income
35
Operating Margin
3.3%
Net Income
-37
Net Margin
-3.5%
EPS (Basic)
$-0.72
EPS (Diluted)
$-0.72
EBITDA
176
EBITDA Margin
16.7%
2019
12/31/2019
Revenue
1,168
Cost of Revenue
312
Gross Profit
856
Gross Margin
73.3%
Operating Income
117
Operating Margin
10.0%
Net Income
65
Net Margin
5.6%
EPS (Basic)
$1.26
EPS (Diluted)
$1.23
EBITDA
200
EBITDA Margin
17.1%
2018
12/31/2018
Revenue
1,102
Cost of Revenue
311
Gross Profit
791
Gross Margin
71.8%
Operating Income
102
Operating Margin
9.3%
Net Income
12
Net Margin
1.1%
EPS (Basic)
$0.24
EPS (Diluted)
$0.24
EBITDA
225
EBITDA Margin
20.4%